BioPortfolio Specialist Market Reports
Biotechnology, Life Science Healthcare and Pharmaceutical Market Research and Corporate Data

Kelly Scientific Reports
Kelly Scientific Publications is a trusted premier provider of cutting edge niche market information within the pharma, biotech and healthcare industries. We are proud to count Fortune 500 companies as many of our repeat corporate clients.
Kelly Scientific Publications provides high quality comprehensive business reports for the Pharma/Biotech industry which are updated regularly. This added value service gives our clients a cutting-edge over their competitors.
Global Medical Aesthetics Industry: Injectables, Energy-Based Devices, Cosmeceuticals, Cosmetic Surgery, Facial Aesthetics, Implants, Cosmetic Tourism. Market Analysis & Forecast to 2022 [Report Updated: 01-08-2017]
Prices Starting From: $3344
save $456 todayKelly Scientific analysis indicates that the current medical aesthetic industry is worth .3 billion for both service and product revenue. Over the next five years a CAGR of 5.5% is expected and the market will hit .6 billion in 2022. Currently, invasive aesthetic procedures generated revenues of over .8 billion, annually. Kelly Scientific analysis indicate that by 2022, invasive aesthetic procedures will grow at a CAGR of 4.3%. Non-invasive procedures generate approximately .7 billio
Published on 2017-08-01
by Kelly ScientificGlobal Regenerative Medicine Market Analysis & Forecast to 2021; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries [Report Updated: 01-05-2017]
Prices Starting From: $4312
save $588 todayThis report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine market was worth .9 billion in 2016 and will grow to over .7 billion by 2021, with a CAGR of 23.3% between this time frame. Within this market, the stem cell industry w
Published on 2017-05-01
by Kelly ScientificGlobal Cancer Immunotherapy Market Analysis & Forecast to 2022 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors [Report Updated: 11-01-2017]
Prices Starting From: $4312
save $588 todayWithin the cancer therapeutics space, which today is worth over 0 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for cancer cells. Today, cancer immunotherapy drugs have captured nearly 50% of the overall oncology drugs market, generating about billion in 2016 alone and are forecast to surpass 0 billion in 2022. This report describes the evolution of such a huge market in 20 chapters
Published on 2017-01-11
by Kelly Scientific
Contact Us for our BEST PRICE Now! +44 7887 945155 Email Us Request a Sample